Genenta Science S.p.A. (NASDAQ: GNTA)
$3.02
-0.5800 ( -16.10% ) 5.8K
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.
Market Data
Open
$3.02
Previous close
$3.60
Volume
5.8K
Market cap
$67.22M
Day range
$3.41 - $3.86
52 week range
$2.20 - $6.19
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 3 | May 03, 2024 |
6-k | Quarterly Reports | 4 | Apr 26, 2024 |
6-k | Quarterly Reports | 1 | Apr 08, 2024 |
6-k | Quarterly Reports | 2 | Apr 02, 2024 |
20-f/a | Annual reports | 20 | Apr 01, 2024 |
20-f | Annual reports | 95 | Mar 29, 2024 |
6-k | Quarterly Reports | 98 | Oct 20, 2023 |